Genome-scale CRISPR Cas9a knockout screen reveals genes that control glioblastoma susceptibility to the alkylating agent temozolomide

Chidiebere U. Awaha Department of Biological Sciences, Hunter College of The City University of New York, New York, NY, USA;b Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USACorrespondence[email protected]

https://orcid.org/0000-0002-3719-8626 View further author information

Jan Winterc Steinbrenner Laborsysteme GmbH, Wiesenbach, GermanyView further author information

Olorunseun O. Ogunwobia Department of Biological Sciences, Hunter College of The City University of New York, New York, NY, USA;b Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA;d Hunter College for Cancer Health Disparities Research, Hunter College of The City University of New York, New York, NY, USAView further author information

References

Awah CU, Chen L, Bansal M, Mahajan A, Winter J, Lad M, Warnke L, Gonzalez-Buendia E, Park C, Zhang D, Feldstein E. 2020. Ribosomal protein S11 influences glioma response to TOP2 poisons. Oncogene. 2020 Jul 39(27):5068–5081.
PubMed Web of Science ®Google Scholar
Awah CU, Winter J, Mazdoom CM, Ogunwobi OO. 2021a. NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to temozolomide (TMZ) via NELFB and RPS6KB2 interaction. Cancer Biol Ther. 39.
Google Scholar
Joung J, Konermann S, Gootenberg JS, Abudayyeh OO, Platt RJ, Brigham MD, Sanjana NE, Zhang F. 2017. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat Protoc. 12(4):828–863.
PubMed Web of Science ®Google Scholar
Stupp R, Taillibert S, Kanner A, Read W, Steinberg DM, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K, Di Meco F. 2017. Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA. 318(23):2306–2316.
PubMed Web of Science ®Google Scholar
Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G. 2010. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 17(1):98–110.
PubMed Web of Science ®Google Scholar
Winter J, Schwering M, Pelz O, Rauscher B, Zhan T, Heigwer F, Boutros M. 2017. CRISPRAnalyzer: interactive analysis, annotation, and documentation of pooled CRISPR screens. BioRxiv. 2017:109967.
Google Scholar

Genome-scale CRISPR Cas9a knockout screen reveals genes that control glioblastoma susceptibility to the alkylating agent temozolomide

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Genome-scale CRISPR Cas9a knockout screen reveals genes that control glioblastoma susceptibility to the alkylating agent temozolomide

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date